Report Detail
Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023
- RnM3925060 |
- 12 March, 2020 |
- Global |
- 404 Pages |
- IQ4I Research & Consultancy |
- Biotechnology
Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.
The global biochips market is expected to grow at double digit CAGR to reach $17,851.1 million by 2023. Biochips market is mainly classified into technologies, products, application and end-users. The global biochips market is broadly classified as micro arrays and microfluidics based on technology. Based on products, the market is classified into Instruments, Reagents & Consumables and Software & Services. Biochips market is segmented on the basis of application as Genomics, Proteomics, Drug discovery, Diagnostics, Food & agricultural testing and others. Genomics application segment is further classified into SNP Genotyping, Gene Expression and Others where as Drug discovery segment is further sub segmented into Target Identification & Validation, HTS (High Throughput screening) and Lead Optimization. Diagnostics segment is further divided into Cancer diagnostics and other diagnostics. End-Users are further classified into Pharmaceutical & Biotech companies, Academic & Research laboratories, Diagnostic laboratories, CROs (Contract and Research Organizations) and others.
Among microarrays and Microfluidics, Microfluidics occupies the major share in 2016 and is expected to grow at a highest CAGR from 2016 to 2023. Among products Reagents & consumables occupy the major share of XX% in 2016 and are expected to grow at a CAGR of XX% from 2016 to 2023 to reach $XX million by 2023. Among Application segment Diagnostics commanded the larger revenue in 2016 and is expected to grow at a highest CAGR of XX% from 2016 to 2023. Among Genomics, SNP genotyping occupies a major share in 2016 with a CAGR of XX% from 2016 to 2023. Target Identification & Validation in Drug discovery segment occupies a major share of XX% in 2016 and similarly other diagnostics occupies a major share of XX% in 2016 and grows with a CAGR of XX% from 2016 to 2023. Diagnostic laboratories occupy a major share of XX% in 2016 and grow with a maximum CAGR of XX% from 2016 to 2023.
Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.
Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.
North America accounts for the highest market share in 2016 and followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favourable government policies makes U.S. the leader of Biochips market. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for biochips and increasing research investments. Asia-Pacific grows with a highest CAGR of XX% from 2016 to 2023.
Major players in biochips market include Abbott laboratories (U.S.), Agilent Technologies (U.S.), Becton-Dickinson Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Illumina (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World
1 EXECUTIVE SUMMARY 29
2 INTRODUCTION 38
- 2.1 KEY TAKE AWAYS 38
- 2.2 REPORT DESCRIPTION 39
- 2.3 MARKETS COVERED 41
- 2.4 STAKEHOLDERS 43
- 2.5 RESEARCH METHODOLOGY 44
- 2.5.1 MARKET SIZE ESTIMATION 45
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 48
- 2.5.3 SECONDARY SOURCES 49
- 2.5.4 PRIMARY SOURCES 50
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 50
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 51
- 2.5.7 ASSUMPTIONS 51
3 MARKET ANALYSIS 53
- 3.1 INTRODUCTION 53
- 3.2 MARKET SEGMENTATION 54
- 3.3 FACTORS INFLUENCING MARKET 56
- 3.3.1 DRIVERS AND OPPORTUNITIES 57
- 3.3.1.1 Increase in usage of biochips in cancer diagnostics 57
- 3.3.1.2 Biochips preference in personalized medicine 57
- 3.3.1.3 Widening application market 58
- 3.3.1.4 Emerging asia pacific market 59
- 3.3.1.5 Increased government funding 60
- 3.3.2 RESTRAINTS AND THREATS 60
- 3.3.2.1 High cost of biochips 60
- 3.3.2.2 Lack of standardization 61
- 3.3.2.3 Limited skilled personnel to work on biochips 61
- 3.3.2.4 Stringent regulations 62
- 3.3.2.5 Adoption of NGS 63
- 3.3.1 DRIVERS AND OPPORTUNITIES 57
- 3.4 PORTER’S FIVE FORCE ANALYSIS 63
- 3.4.1 THREAT OF NEW ENTRANTS 64
- 3.4.2 THREAT OF SUBSTITUTES 65
- 3.4.3 RIVALRY AMONG EXISTING COMPETITORS 65
- 3.4.4 BARGAINING POWER OF SUPPLIERS 66
- 3.4.5 BARGAINING POWER OF BUYERS 66
- 3.5 REGULATORY GUIDELINES 67
- 3.5.1 UNITED STATES 67
- 3.5.2 EUROPE 68
- 3.5.3 CHINA 68
- 3.5.4 INDIA 69
- 3.5.5 JAPAN 70
- 3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 71
- 3.6.1 MICROARRAY TECHNOLOGY GLOBAL MARKET SHARE ANALYSIS BY
MAJOR PLAYERS 73
- 3.6.2 MICROFLUIDIC TECHNOLOGY GLOBAL MARKET SHARE ANALYSIS
BY MAJOR PLAYERS 75
- 3.7 PATENT TRENDS 77
- 3.8 SUPPLY CHAIN ANALYSIS 79
- 3.9 BIOCHIPS UNDER CLINICAL TRIAL 81
- 3.10 NEW PRODUCT LAUNCHES 83
- 3.11 TECHNOLOGICAL ADVANCEMENTS 89
- 3.11.1 “LAB ON A CHIP’ THAT COSTS 1 CENT TO MAKE 89
- 3.11.2 LIGHT BASED LAB-ON-A-CHIP DEVICE 89
- 3.11.3 NEW NEURO CHIP 90
- 3.11.4 3D PRINTED ORGAN-ON-A-CHIP 90
- 3.11.5 LIQUID BIOPSY CHIPS FOR THE DETECTION OF METASTATIC
CANCER CELLS 91
- 3.11.6 PLACENTA ON A CHIP 92
4 BIOCHIPS GLOBAL MARKET, BY TECHNOLOGY 93
- 4.1 INTRODUCTION 93
- 4.2 MICROARRAYS 95
- 4.2.1 DNA MICROARRAYS 99
- 4.2.2 PROTEIN MICROARRAYS 103
- 4.2.3 TISSUE MICROARRAYS 110
- 4.2.4 CELL MICROARRAYS 113
- 4.2.5 OTHER MICROARRAYS 114
- 4.3 LAB-ON-A-CHIP (MICROFLUIDICS) 116
- 4.3.1 PCR-ON-A-CHIP 120
- 4.3.2 IMMUNOASSAYS-ON-A-CHIP 123
- 4.3.3 ELECTROPHORESIS-ON-A-CHIP 126
- 4.3.4 FLOW CYTOMETRY-ON-A-CHIP 128
- 4.3.5 NGS-ON-A-CHIP 130
- 4.3.6 ORGAN-ON-CHIP 132
- 4.3.7 OTHERS 134
5 BIOCHIPS GLOBAL MARKET, BY PRODUCTS 138
- 5.1 INTRODUCTION 138
- 5.2 INSTRUMENTS 141
- 5.3 REAGENTS AND CONSUMABLES 143
- 5.4 SOFTWARE AND SERVICES 145
6 BIOCHIPS GLOBAL MARKET, BY APPLICATIONS 149
- 6.1 INTRODUCTION 149
- 6.2 GENOMICS 152
- 6.2.1 GENE EXPRESSION 154
- 6.2.2 SNP GENOTYPING 156
- 6.2.3 OTHER GENOMICS 159
- 6.3 PROTEOMICS 161
- 6.4 DRUG DISCOVERY & DEVELOPMENT 164
- 6.4.1 TARGET IDENTIFICATION AND VALIDATION 166
- 6.4.2 HIGH THROUGHPUT SCREENING 169
- 6.4.3 LEAD OPTIMIZATION 172
- 6.5 DIAGNOSTICS 174
- 6.5.1 CANCER DIAGNOSTICS 176
- 6.5.2 OTHER DIAGNOSTICS 178
- 6.6 FOOD AND AGRICULTURE TESTING 180
- 6.7 OTHERS 182
7 BIOCHIPS GLOBAL MARKET, BY END-USERS 186
- 7.1 INTRODUCTION 186
- 7.2 PHARMACEUTICAL AND BIOTECH COMPANIES 189
- 7.3 ACADEMIC & RESEARCH LABORATORIES 191
- 7.4 CONTRACT RESEARCH ORGANISATIONS 193
- 7.5 DIAGNOSTIC LABORATORIES 195
- 7.6 OTHERS 196
8 REGIONAL MARKET ANALYSIS 198
- 8.1 INTRODUCTION 198
- 8.2 NORTH AMERICA 200
- 8.2.1 U.S. 215
- 8.2.2 OTHERS 218
- 8.3 EUROPE 221
- 8.3.1 GERMANY 235
- 8.3.2 U.K. 237
- 8.3.3 FRANCE 240
- 8.3.4 OTHERS 242
- 8.4 ASIA-PACIFIC 245
- 8.4.1 CHINA 260
- 8.4.2 JAPAN 263
- 8.4.3 INDIA 266
- 8.4.4 OTHERS 269
- 8.5 REST OF THE WORLD 272
- 8.5.1 BRAZIL 286
- 8.5.2 REST OF LATIN AMERICA 288
- 8.5.3 MIDDLE EAST AND OTHERS 290
9 COMPETITIVE LANDSCAPE 293
- 9.1 INTRODUCTION 293
- 9.2 NEW PRODUCT LAUNCHES 294
- 9.3 AGREEMENTS, PARTNERSHIP, COLLABORATION & JOINT VENTURES 299
- 9.4 APPROVALS 302
- 9.5 MERGERS & ACQUISITIONS 307
- 9.6 OTHER DEVELOPMENTS 309
10 MAJOR COMPANIES 310
- 10.1 ABBOTT LABORATORIES 310
- 10.1.1 OVERVIEW 310
- 10.1.2 FINANCIALS 311
- 10.1.3 PRODUCT PORTFOLIO 314
- 10.1.4 KEY DEVELOPMENTS 315
- 10.1.5 BUSINESS STRATEGY 316
- 10.1.6 SWOT ANALYSIS 317
- 10.2 AGILENT TECHNOLOGIES, INC. 318
- 10.2.1 OVERVIEW 318
- 10.2.2 FINANCIALS 319
- 10.2.3 PRODUCT PORTFOLIO 322
- 10.2.4 KEY DEVELOPMENTS 325
- 10.2.5 BUSINESS STRATEGY 327
- 10.2.6 SWOT ANALYSIS 328
- 10.3 BECTON DICKINSON AND COMPANY 329
- 10.3.1 OVERVIEW 329
- 10.3.2 FINANCIALS 330
- 10.3.3 PRODUCT PORTFOLIO 333
- 10.3.4 KEY DEVELOPMENTS 334
- 10.3.5 BUSINESS STRATEGY 335
- 10.3.6 SWOT ANALYSIS 336
- 10.4 BIO-RAD LABORATORIES 337
- 10.4.1 OVERVIEW 337
- 10.4.2 FINANCIALS 338
- 10.4.3 PRODUCT PORTFOLIO 340
- 10.4.4 KEY DEVELOPMENTS 343
- 10.4.5 BUSINESS STRATEGY 344
- 10.4.6 SWOT ANALYSIS 345
- 10.5 DANAHER CORPORATION 346
- 10.5.1 OVERVIEW 346
- 10.5.2 FINANCIALS 347
- 10.5.3 PRODUCT PORTFOLIO 350
- 10.5.4 KEY DEVELOPMENTS 353
- 10.5.5 BUSINESS STRATEGY 357
- 10.5.6 SWOT ANALYSIS 358
- 10.6 FLUIDIGM CORPORATION 359
- 10.6.1 OVERVIEW 359
- 10.6.2 FINANCIALS 360
- 10.6.3 PRODUCT PORTFOLIO 363
- 10.6.4 KEY DEVELOPMENTS 367
- 10.6.5 BUSINESS STRATEGY 369
- 10.6.6 SWOT ANALYSIS 370
- 10.7 GE HEALTHCARE 371
- 10.7.1 OVERVIEW 371
- 10.7.2 FINANCIALS 372
- 10.7.3 PRODUCT PORTFOLIO 374
- 10.7.4 KEY DEVELOPMENTS 375
- 10.7.5 BUSINESS STRATEGY 376
- 10.7.6 SWOT ANALYSIS 377
- 10.8 ILLUMINA, INC. 378
- 10.8.1 OVERVIEW 378
- 10.8.2 FINANCIALS 379
- 10.8.3 PRODUCT PORTFOLIO 380
- 10.8.4 KEY DEVELOPMENTS 383
- 10.8.5 BUSINESS STRATEGY 383
- 10.8.6 SWOT ANALYSIS 384
- 10.9 PERKINELMER, INC. 385
- 10.9.1 OVERVIEW 385
- 10.9.2 FINANCIALS 386
- 10.9.3 PRODUCT PORTFOLIO 388
- 10.9.4 KEY DEVELOPMENTS 391
- 10.9.5 BUSINESS STRATEGY 391
- 10.9.6 SWOT ANALYSIS 392
- 10.10 THERMOFISHER SCIENTIFIC INC. 393
- 10.10.1 OVERVIEW 393
- 10.10.2 FINANCIALS 394
- 10.10.3 PRODUCT PORTFOLIO 396
- 10.10.4 KEY DEVELOPMENTS 401
- 10.10.5 BUSINESS STRATEGY 402
Summary:
Get latest Market Research Reports on Biochips (Microarrays/Microfluidics). Industry analysis & Market Report on Biochips (Microarrays/Microfluidics) is a syndicated market report, published as Biochips (Microarrays/Microfluidics) Global Market – Forecast To 2023. It is complete Research Study and Industry Analysis of Biochips (Microarrays/Microfluidics) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
